Over a Dozen Pharma Executives Resign for Personal Reasons, Including CEOs and VPs, Amid Recent IPO Filings

　　【Pharmaceutical Network Industry Dynamics】According to incomplete industry statistics, since June, there have been frequent personnel changes in pharmaceutical companies, with at least 109 senior executives from 36 pharmaceutical enterprises affected. Among them, more than 10 senior executives resigned for personal reasons, involving companies such as Guangyuzhi, Jichuan Pharmaceutical, Zhenghai Bio, Taiantang, Hocer Diagnostics, David Medical, Yipinhong, Daan Gene, Jianfan Bio, Northeast Pharmaceutical, and Sunnyou. The positions these executives resigned from include levels such as General Manager, Vice President, and Deputy General Manager.
 

On June 21, Guangyuzhong announced that the company's vice presidents, Zhang Yi and Liang Peng, had resigned for personal reasons. Meanwhile, Zhang Bin of Guangyuzhong’s controlling subsidiary, Shanxi Guangyuzhong, stepped down as chairman of Shanxi Guangyuzhong. According to relevant regulations, Shanxi Guangyuzhong is required to change its legal representative to the current chairman, Lü Hongyu.
 

On June 17, the board of directors of Jichuan Pharmaceutical received a written resignation report submitted by Liu Jun, a director and deputy general manager. Due to personal reasons, Liu Jun applied to resign from the positions of director and deputy general manager, and will not hold any other positions in the company after resignation.
 

On June 17, Zhenghai Bio announced that the company's board of directors had recently received a written resignation report from Shi Yanfeng, the company's vice general manager. The announcement showed that Shi Yanfeng applied to resign from the position of vice general manager of Zhenghai Bio for personal reasons, and would no longer hold any position in Zhenghai Bio after resignation.
 

On the evening of June 15, Tai'an Tang announced that due to personal reasons, Mr. Zhuang Qiming has applied to resign from his position as the company's vice general manager. After his resignation, Mr. Zhuang will no longer hold any position in the company or its subsidiaries.
 

On June 14, HAEOT announced that the board of directors has approved the election of Mr. Wang Kai as the vice chairman of the second board of directors. His term will last from the date of approval by this board meeting until the end of the term of the second board of directors. Meanwhile, Mr. Wang Kai has applied to the company's board of directors to resign from his position as vice general manager. After his resignation, Mr. Wang Kai will continue to serve as a director and the board secretary.
 

On the evening of June 10, Jianfan Biotech announced that the company's board of directors received a written resignation report from Mr. He Xiaolian, the company’s financial director, on June 10, 2022. Mr. He Xiaolian applied to resign from his position as financial director due to personal reasons and will no longer hold any position in the company after his resignation.
 

On June 9, David Medical announced that the company's board of directors received a written resignation report from Ma Jianmin, the company's vice general manager, on June 8, 2022. It is reported that Ma Jianmin applied to resign from the position of vice general manager of David Medical due to personal reasons. At the same time, he also resigned from the positions of general manager of Ningbo Wellkede Medical Device Co., Ltd., a subsidiary of David Medical, and executive director and general manager of Ningbo Yongxing Medical Instrument Co., Ltd., a subsidiary of David Medical.
 

On June 8, Northeast Pharmaceutical announced that the company had received a resignation report from Xu Lei on June 7, 2022. Xu Lei applied to resign from the position of Chief Financial Officer due to personal reasons.
 

On June 7, Yipinhong announced that the company's board of directors recently received a written resignation report submitted by Xie Xiaohua, the company’s vice general manager and board secretary. Xie Xiaohua applied to resign from the positions of vice general manager and board secretary due to personal reasons and will no longer hold any position in the company after resignation.
 

On the evening of June 6, Daan Gene announced that the company's board of directors received a written resignation report from the general manager, Mr. Zhou Xinyu, on June 6, 2022. He resigned from his position as general manager due to personal and health reasons. After stepping down as general manager, Mr. Zhou Xinyu will no longer hold any position in the company or its subsidiaries. Subsequently, on June 24, three newly appointed directors, Zhang Bin, Huang Luo, and Jiang Xiwen, were approved at the company’s general meeting. Thus, the controversy surrounding the board of directors' transition since May has finally been resolved.
 

On June 1, Sunnyou Medical announced that the company's board of directors had recently received the resignation report from Liu Jing, the company's board secretary. Due to personal reasons, Ms. Liu Jing applied to resign from her position as the board secretary. After her resignation, Ms. Liu Jing will no longer hold any position in the company.
 

Click to Enter the Exhibition Page